Phenotypic heterogeneity and associations of two aldose reductase gene polymorphisms with nephropathy and retinopathy in type 2 diabetes

被引:84
|
作者
Wang, Y
Ng, MCY
Lee, SC
So, WY
Tong, PCY
Cockram, CS
Critchley, JAJH
Chan, JCN [1 ]
机构
[1] Chinese Univ Hong Kong, Div Clin Pharmacol, Prince Wales Hosp, Shatin, NT, Peoples R China
[2] Chinese Univ Hong Kong, Div Endocrinol, Dept Med & Therapeut, Prince Wales Hosp, Shatin, NT, Peoples R China
关键词
D O I
10.2337/diacare.26.8.2410
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
OBJECTIVE - We investigated the phenotypic features of diabetic microvascular complications and their association with a (CA)(n) microsatellite and a C/T polymorphism at the 5' region of the aldose reductase gene (ALR2) in a consecutive cohort of 738 Chinese type 2 diabetic patients. RESEARCH DESIGN AND METHODS - Of the entire patient cohort, 392 were free of diabetes complications, or uncomplicated, 159 had diabetic nephropathy, 66 had diabetic retinopathy, and 121 had both diabetic nephropathy and retinopathy. Nephropathy was defined as urinary albumin excretion rate (AER) greater than or equal to20 mug/min and albumin-to-creatinine ratio greater than or equal to3.5 mg/mmol in two urine collections. Retinopathy was defined by the presence of hemorrhages, exudates, laser marks, and fibrous proliferation or by a history of vitrectomy. (CA)(n) and C/T polymorphisms were examined by PCR followed by capillary electrophoresis and digestion with BfaI, respectively. RESULTS - in the whole cohort, patients with diabetic retinopathy (n = 187) had higher blood pressure and lower BMI, while those with diabetic nephropathy (n = 280) had higher blood pressure, waist-to-hip ratio, and lipid profile than those without the respective complications. The z+6 carriers of the (CA)(n) polymorphism were less common in patients with diabetic retinopathy than those without diabetic retinopathy (n = 551) (4.3 vs. 9.3%, P = 0.04). The CT/TT carriers had a higher AER than the CC carriers (30.2 X/divided by 7.2 vs. 21.9 X/divided by, 6.9 mug/min, P = 0.03). Further subgroup analysis was performed after excluding uncomplicated patients with <5 years disease duration. The group with both diabetic nephropathy and retinopathy had higher frequencies of the z-2 allele (25.7 vs. 16.9%, P = 0.03) and T allele (26.4 vs. 18.5%, P = 0.04) and a lower frequency of the z+6 allele (1.7 vs. 5.5%, P = 0.054) than the uncomplicated group. Multiple logistic regression analysis confirmed that z-2 carrying (odds ratio 2.6, 95% CI 1.20-5.83, P = 0.02) and CT/TT genotypes (OR 2.5, 95% CI 1.19-5.19, P = 0.02) were independent predictors for both diabetic nephropathy and retinopathy. CONCLUSIONS - Chinese type 2 diabetic patients exhibited phenotypic differences in terms of risk factors for both diabetic nephropathy and diabetic retinopathy. Both the z-2 allele of (CA)(n) polymorphism and T allele of ALR2 were independently associated with severe diabetic microvascular complications.
引用
收藏
页码:2410 / 2415
页数:6
相关论文
共 50 条
  • [31] Astaxanthin inhibits aldose reductase activity in Psammomys obesus, a model of type 2 diabetes and diabetic retinopathy
    Benlarbi-Ben Khedher, Maha
    Hajri, Khouloud
    Dellaa, Ahmed
    Baccouche, Basma
    Hammoum, Mane
    Boudhrioua-Mihoubi, Nourhene
    Dhifi, Wissal
    Ben Chaouacha-Chekir, Afika
    FOOD SCIENCE & NUTRITION, 2019, 7 (12): : 3979 - 3985
  • [32] PPARɣ2, aldose reductase, and TCF7L2 gene polymorphisms: relation to diabetes mellitus
    Hadeel Ahmed Shawki
    Ekbal M. Abo-hashem
    Magdy M. Youssef
    Maha Shahin
    Rasha Elzehery
    Journal of Diabetes & Metabolic Disorders, 2022, 21 : 241 - 250
  • [33] A novel polymorphism in the aldose reductase gene promoter region is strongly associated with diabetic retinopathy in adolescents with type 1 diabetes
    Kao, YL
    Donaghue, K
    Chan, A
    Knight, J
    Silink, M
    DIABETES, 1999, 48 (06) : 1338 - 1340
  • [34] Glucose transporter 5 and aldose reductase gene expression profiles and susceptibility to diabetic nephropathy in patients with type 1 diabetes
    Hodgkinson, AD
    Millward, A
    Demaine, AG
    DIABETES, 2001, 50 : A176 - A176
  • [35] The role of aldose reductase gene in the susceptibility to diabetic nephropathy in Type II (non-insulin-dependent) diabetes mellitus
    Moczulski, DK
    Burak, W
    Doria, A
    Zychma, M
    Zukowska-Szczechowska, E
    Warram, JH
    Grzeszczak, W
    DIABETOLOGIA, 1999, 42 (01) : 94 - 97
  • [36] Methylenetetrahydrofolate reductase gene polymorphism is not associated to diabetic nephropathy in type 2 diabetes
    Scaglione, L
    Gambino, R
    Gay, M
    Lillaz, E
    Cassader, M
    Pagano, G
    Cavallo-Perin, P
    DIABETOLOGIA, 1999, 42 : A329 - A329
  • [37] Association of methylenetetrahydrofolate reductase gene polymorphism and diabetic nephropathy in type 2 diabetes?
    Blüthner, M
    Brüntgens, A
    Schmidt, S
    Strojek, K
    Grzeszczak, W
    Ritz, E
    NEPHROLOGY DIALYSIS TRANSPLANTATION, 1999, 14 (01) : 56 - 57
  • [38] The aldose reductase promoter gene-106 C/T mutation is not associated with nephropathy but is a determinant of retinopathy in type 1 diabetic patients
    Fanelli, A
    Hadjadj, S
    Gallois, Y
    Fumeron, F
    Chatellier, G
    Betoule, D
    Grandchamp, B
    Marre, M
    DIABETES, 2002, 51 : A512 - A512
  • [39] Aldose-reductase gene polymorphisms and peripheral nerve function in Type 2 diabetic patients.
    Sivenius, K
    Partanen, J
    Niskanen, L
    Laakso, M
    Uusitupa, M
    DIABETOLOGIA, 2003, 46 : A313 - A314